Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00118352
Status:
COMPLETED
Last Update Posted:
2017-05-30
First Post:
2005-07-08
Brief Title:
Alemtuzumab Fludarabine Phosphate and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Fred Hutchinson Cancer Center
Organization Data
Organization:
Fred Hutchinson Cancer Center
Class:
OTHER
Study ID:
195900
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fred Hutchinson Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
Brenda Sandmaier
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Fred Hutchinson Cancer Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |